India to Sri Lanka: Rosuvastatin Export Trade Route
India has recorded 410 verified shipments of Rosuvastatin exported to Sri Lanka, representing a combined trade value of $8.8M USD. This corridor is served by 37 active Indian exporters, with an average shipment value of $21.5K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 31% of total export value with 40 shipments worth $2.7M USD. On the buying side, SUNSHINE HEALTHCARE LANKA LIMITED is the largest importer in Sri Lanka with $2.0M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED, CIPLA LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Sri Lanka Rosuvastatin corridor is one of India's established pharmaceutical export routes, with 410 shipments documented worth a combined $8.8M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 31% of all export value, reflecting the consolidated nature of India's rosuvastatin manufacturing sector.
Across 37 active suppliers, the average shipment value stands at $21.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with rosuvastatin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 16.5%, placing it at rank #13 among India's top rosuvastatin export destinations globally.
On the import side, key buyers of Indian rosuvastatin in Sri Lanka include SUNSHINE HEALTHCARE LANKA LIMITED, BREATHEFREE LANKA PVT LTD , NOTIFY EMERCHEME NB CEYLON LIMITED and 60 others. SUNSHINE HEALTHCARE LANKA LIMITED is the single largest importer with 56 shipments valued at $2.0M USD.
